AMALY — SHARIAH COMPLIANCE REPORT
==================================
Symbol: NRSN
Report Date: 2026-09-04
Full Report: https://amaly.io/stock/NRSN

EXECUTIVE SUMMARY
------------------
Compliance Status: NON_COMPLIANT
Quality Rating: B
Description: NRSN, a clinical-stage biotechnology company focused on developing treatments for neurodegenerative diseases, demonstrates strong financial metrics with zero debt and low liquidity ratios relative to market capitalization. However, insufficient data on income sources leads to uncertainties in non-compliant income assessment. The company's business activities are fully permissible under Shariah principles, emphasizing preservation of life. Despite compliant ratios under AAOIFI standards, non-inclusion in major Shariah indices results in an overall NON_COMPLIANT status. Investors should monitor ongoing clinical trials and financial disclosures for potential improvements in compliance visibility.

Primary Compliance Concerns:
- Non-inclusion in major Shariah indices due to small market capitalization and liquidity filters
- Insufficient data on interest and non-permissible income ratios, requiring further verification
- Limited historical financial data impacting trend analysis

Purification Requirement: 0.00%
Index Inclusion: Not included in any of the four major Shariah indices (S&P, MSCI, FTSE, DJIM)

KEY FINANCIAL METRICS
----------------------
Debt Ratio: 0.0%
Liquidity Ratio: 0.0%
Interest Income Ratio: 0.0%
Purification Required: 0.00%

INDEX INCLUSION STATUS
-----------------------
S&P Shariah: EXCLUDED
MSCI Islamic: EXCLUDED
DJIM: EXCLUDED
FTSE Shariah: EXCLUDED
Total: 0 of 4
Last Verified: 2025-09-01

REPORTING PERIOD
-----------------
Latest Annual Report: FY 2025
Latest Quarterly Data: Q4 2025
Trend Period: FY 2020 to FY 2025
Data Retrieved: 2026-02-20T00:00:00Z

---
Full interactive report: https://amaly.io/stock/NRSN
Provided by Amaly (https://amaly.io) — Shariah Compliant Stock Screener
Disclaimer: This data is for informational purposes only and does not constitute financial or religious advice.